Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple cellular components in microorganisms is a collective term used to describe the various structural and functional elements targeted by broad-spectrum antimicrobial agents, primarily antiseptics and disinfectants. Unlike traditional antibiotics that target specific enzymes or ribosomes, these agents exert their effects through non-specific mechanisms such as the denaturation of essential proteins, the dissolution of lipid bilayers in cell membranes, and the oxidation of vital cellular constituents (McDonnell & Russell, 1999, Clinical Microbiology Reviews). This multi-faceted attack is effective against a wide array of pathogens, including bacteria, viruses, and fungi, and significantly reduces the likelihood of the organism developing resistance due to the simultaneous disruption of multiple vital systems (CDC, 2008, Guideline for Disinfection and Sterilization). These interactions are fundamental to clinical practices involving skin antisepsis, wound care, and the sterilization of medical instruments (StatPearls, 2023, Antiseptics and Disinfectants). However, because these mechanisms are often non-selective, they can also cause damage to human host cells, leading to potential safety concerns like tissue irritation or impaired wound healing if used inappropriately (NIH, 2022, PubChem). Consequently, this target designation is often used in pharmacological databases to categorize agents with a non-molecularly defined, broad-spectrum mode of action.
Non-specific disruption of microbial structures through protein denaturation, lipid membrane dissolution, and oxidative damage to nucleic acids and enzymes.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple cellular components in microorganisms.